Zantac Patients Are Advised Not To Abuse Their New PPI Drugs
Zantac users have switched to Prilosec, Nexium, and other PPI drugs that may have dangerous side effects also
Tuesday, September 15, 2020 - By now, everyone who was taking Zantac for treating heartburn and acid reflux is aware of the drug's recall over fears that patients have developed cancer. Thousands of users have filed lawsuits alleging that the drug has caused cancer of the stomach, bladder, colon, and many others. Storing Zantac in high temperatures may cause NDMA, a deadly carcinogen, to increase to dangerously high levels. The drug's interaction with stomach nitrites could also cause abnormalities. Zantac users are afraid they may have exposed themselves to carcinogenic levels of NDMA by taking the manufacturer's recommended dosage of the product or having exceeded the dosage. Lawsuits claim that records show Sanofi knew for decades that elevated levels of NDMA in Zantac might cause cancer, and the company may have lied to the FDA and failed to warn consumers. Doctors recommended patients switch from the H2 antagonist drug to a different type of heartburn medication called protein pump inhibitors (PPI)s for relief of their painful condition when the FDA recalled Zantac earlier in the year. Heartburn and acid reflux pain is not to be taken lightly as stomach acids that back up into the esophagus can result in irritation leading to cancer. All was thought to be well with switching drugs from H2s to PPIs, however, it looks like PPI drugs may have new and potentially severe health consequences of their own. It looks like PPI drugs Prilosec, Prilosec OTC, Zegerid, Prevacid, Protonix, Aciphex, Nexium, and Dexilantmay may cause brain damage if abused according to a doctor studying the side effects of Zantac alternative drugs.
Naveed Saleh, MD, MS, is warning people that they may have accidentally overdosed on popular over-the-counter heartburn medicines called protein-pump inhibitors (PPI) and are unaware of the severe side effects the drug can have. PPI drugs attach themselves to proteins and block the production of stomach acid for heartburn and acid reflux pain relief. Zantac heartburn medicine cancer lawsuit claims are being accepted for review before filing a lawsuit claim and attorneys handling Zantac cancer lawsuits offer a free no obligation consultation.
Dr. Saleh tells MD Linx.com that patients have been abusing the dosing recommendations of PPI drugs. Dr. Saleh claims that taking PPI drugs can cause Vitamin B12 deficiency and lead to medical problems. According to a large study recently published in the JAMA Kaiser Permanente. "(the study) found that patients who took PPIs for two or more years were more likely to experience vitamin B12 deficiency, and doses of more than 1.5 pills per day were more strongly linked with the condition than doses of less than 0.75 pills per day. Untreated vitamin B12 deficiency can lead to dementia, neurologic damage, anemia, and other complications."
You may qualify to file a claim against Sanofi and seek reimbursement for medical expenses, lost income, pain, and suffering, or any other related damages if you or a loved one have developed cancer of the stomach, bladder, breast, colon, esophageal, or another form of cancer and have used or abused Zantac for over one year.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.